PIN24 THE COST-EFFECTIVENESS OF A QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINE (6, I 1,6, 18) IN NORWAY
Abstract
Authors
E Dasbach E Elbasha R Insinga J Nygard
E Dasbach E Elbasha R Insinga J Nygard
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now